leadf
logo-loader
viewAdalta Ltd

AdAlta with Proactive at ASX Small and Mid-Cap Conference

AdAlta Ltd (ASX:1AD) managing director and CEO Tim Oldham speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap conference 2020.

The innovative biotech company has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein -the result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases.

Quick facts: Adalta Ltd

Price: 0.11 AUD

ASX:1AD
Market: ASX
Market Cap: $26.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Adalta Ltd named herein, including the promotion by the Company of Adalta Ltd in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Tony Locantro says stocks now falling to 'decent values' amidst market...

Alto Capital's Tony Locantro says we're now seeing some long overdue volatility in the market and stocks falling to decent values. ''We had the Dow Jones up above 28,000, we had gold knocking on US$2000, both of those were extremely crowded trades''. ''We had the NASDAQ at stupid levels as well...

on 27/9/20

2 min read